Capitol Clarity / Firms / Crispr Therapeutics, Inc.

Crispr Therapeutics, Inc.

Crispr Therapeutics, Inc. lobbies on its own behalf. For Q2 2026 it reported $0 across 1 client report and lists 0 lobbyists across its filings.

Clients, Q2 2026

Client	Reported	Issues
CRISPR THERAPEUTICS, INC.	$0

Year	Reported	Clients
2026	$0	1
2025	$0	1

Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.